Seeking Alpha
01 Nov 2025, 11:23 UTC · 46w ago
Verdict
Source says Downgrade to Hold. We score CLVT −0.60 across four claims.
Score confirms the headline.
Downgrade to Hold
Rating stated in the headline
−0.60strongly bearish
What the story claims
4 claims · scored −1 bearish … +1 bullish
Clarivate's organic growth trends have turned negative and recovery is lagging expectations.
So whatNegative organic growth is a primary indicator of fundamental business decline, leading to valuation downgrades.
More negative than 99% of claims this week
Core business weakness persists specifically within the IP and Life Sciences & Healthcare segments.
Continue reading
5 related stories
More negative than 80% of ticker scores this week
Scored by the NIS engine · methodology.
More negative than 95% of claims this week
Q3 2025 results showed flat revenue.
More negative than 87% of claims this week
The company is seeing positive traction in AI products, subscription mix, and ACV growth.
More positive than 63% of claims this week
Which stocks this story touches
More negative than 80% of ticker scores this week
The company was downgraded from buy to hold due to negative organic growth trends and lagging recovery.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−45.0%
Price agrees with the score
$1.87 vs $3.40 close before publication (Oct 31) · not market-adjusted
CLVT chart →
